









Markets
/
Stocks
/
nasdaq-zimv
/

ZimVie Inc

ZIMV

18.900USD

+0.020+0.11%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

532.92MMarket Cap

LossP/E TTM



ZimVie Inc

18.900

+0.020+0.11%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

113 / 207

Overall Ranking

286 / 4721

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Hold

Current Rating

16.000

Target Price

-15.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.

Undervalued

The company’s latest PE is -26.85, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 24.71M shares, decreasing 12.21% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.78M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.16.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 7.21, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 116.66M, representing a year-over-year decrease of 0.13%, while its net profit experienced a year-over-year decrease of 1.67%.

Score

Industry at a Glance

Previous score

7.21

Change



Financials

6.73

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

5.83

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.23

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.27

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -26.82, which is -94.98% below the recent high of -1.35 and 84.37% above the recent low of -4.19.

Score

Industry at a Glance

Previous score

1.20

Change

1.6

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 113/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 6.00, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for ZimVie Inc is 19.00, with a high of 19.00 and a low of 10.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Hold

Current Rating

16.000

Target Price

-15.25%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

ZimVie Inc

ZIMV

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 4.26, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 18.98 and the support level at 18.81, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.26

Change

0.12

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.303

Neutral

RSI(14)

75.070

Buy

STOCH(KDJ)(9,3,3)

51.492

Buy

ATR(14)

0.057

Low Volatility

CCI(14)

43.670

Neutral

Williams %R

64.706

Sell

TRIX(12,20)

0.163

Sell

StochRSI(14)

71.310

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

18.886

Buy

MA10

18.877

Buy

MA20

18.900

Sell

MA50

17.459

Buy

MA100

13.273

Buy

MA200

12.978

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-18

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 87.74%, representing a quarter-over-quarter decrease of 0.24%. The largest institutional shareholder is The Vanguard, holding a total of 1.78M shares, representing 6.30% of shares outstanding, with 1.32% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Eversept Partners, LP

2.08M

+0.42%

The Vanguard Group, Inc.

Star Investors

1.76M

-0.61%

BlackRock Institutional Trust Company, N.A.

1.78M

+0.92%

J. Goldman & Co., L.P.

1.45M

+1.54%

Dimensional Fund Advisors, L.P.

1.32M

+5.77%

Gabelli Funds, LLC

739.74K

+21.20%

Neuberger Berman, LLC

1.33M

+1.68%

American Century Investment Management, Inc.

690.67K

+9.97%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.41, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 2.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.